Current Neuropharmacology
Title: Editorial [Hot Topic: The Pros of Not Being Competitive (Allosteric Modulation of GPCRs) (Guest Editors: Vincent Mutel and Bernhard Bettler)]
Volume: 5 Issue: 3
Author(s): Vincent Mutel and Bernhard Bettler
Affiliation:
Export Options
About this article
Cite this article as:
Mutel Vincent and Bettler Bernhard, Editorial [Hot Topic: The Pros of Not Being Competitive (Allosteric Modulation of GPCRs) (Guest Editors: Vincent Mutel and Bernhard Bettler)], Current Neuropharmacology 2007; 5 (3) . https://dx.doi.org/10.2174/157015907781695964
DOI https://dx.doi.org/10.2174/157015907781695964 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Novel Pharmacologic Approaches to the Management of Sepsis: Targeting the Host Inflammatory Response
Recent Patents on Inflammation & Allergy Drug Discovery Impact of Jugular Vein Valve Function on Cerebral Venous Haemodynamics
Current Neurovascular Research Successful Treatment of Pulmonary Hemorrhage Associated with Pediatric Tsutsugamushi Disease by Chloromycetin
Current Signal Transduction Therapy Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
Current Gene Therapy The Use of Anti-Epileptic Medication in Women with Affective Disorders in Early and Late Pregnancy and During Breastfeeding
Current Women`s Health Reviews Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases
CNS & Neurological Disorders - Drug Targets Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Current Protein & Peptide Science A Comparative Analysis of Brain and Plasma Aβ Levels in Eight Common Non-Transgenic Mouse Strains: Validation of a Specific Immunoassay for Total Rodent Aβ
Current Alzheimer Research Dietary Interventions for Diabetic Neuropathy & Nephropathy: A Review
Current Psychopharmacology Understanding the Structural Basis for Inhibition of Cyclin-Dependent Kinases. New Pieces in the Molecular Puzzle
Current Drug Targets Serum Albumin Concentration and Cognitive Impairment
Current Alzheimer Research Tau Pathology and Future Therapeutics
Current Alzheimer Research Drug Evolution: p-Aminobenzoic Acid as a Building Block
Current Medicinal Chemistry Molecular Aspects of Melatonin Treatment in Tinnitus: A Review
Current Drug Targets BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on Bioactivity
Recent Patents on CNS Drug Discovery (Discontinued) Pathological Peptide Folding in Alzheimers Disease and Other Conformational Disorders
Current Medicinal Chemistry The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Current Pharmaceutical Design Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Computational Medicinal Chemistry for Rational Drug Design: Identification of Novel Chemical Structures with Potential Anti-Tuberculosis Activity
Current Topics in Medicinal Chemistry Clinical Applications of Non-Antimicrobial Actions of Tetracyclines in Inflammatory Diseases
Current Drug Therapy